Evidence map›Paper›PMID 38170177›Full record

ArticleSubstance use & misuse2024

First Used Nicotine/Cannabis Product and Associated Outcomes in Late Adolescents.

Laura E Hatz, Kelly E Courtney, Natasha E Wade, Courtney Thompson, Rachel Baca, Gianna Andrade, Neal Doran, Joanna Jacobus

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Substance use & misuse, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Laura E HatzDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Kelly E CourtneyDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Natasha E WadeDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-9629-2305
Courtney ThompsonDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Rachel BacaDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Gianna AndradeDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Neal DoranDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Joanna JacobusDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
University of California San Diego · US

Funding

ABCD-USA Consortium: Research ProjectU01DA041089 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Joanna Jacobus, Susan F. Tapert · 2015 to 2026
$31.7M
Alcohol Research in the Science/Practitioner ModelT32AA013525 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI EDWARD P RILEY, ANDREA SPADONI TOWNSEND · 2002 to 2026
$8.4M
Cannabis and Nicotine Co-Use Influences on Protracted Development of Neural Structure and FunctionR01DA054106 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Joanna Jacobus · 2021 to 2026
$3.2M
Vaping in Childhood and Adolescence: Cognitive and Behavioral ConsequencesR01DA054980 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Neal Doran, Joanna Jacobus · 2022 to 2026
$1.4M
Effects of Comorbid Cannabis and Tobacco Product Use on Adolescent NeurodevelopmentR21DA047953 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JACOBUS, JOANNA · 2019 to 2020
$433k
NIAAA NIH HHS T32 AA013525NIDA NIH HHS R01 DA054106NIDA NIH HHS R01 DA054980NIDA NIH HHS R21 DA047953NIDA NIH HHS U01 DA041089
6 · The paper itself

Abstract

backgroundNicotine and tobacco product (NTP) and cannabis use are common in adolescence/young adulthood and increase risk for negative psychosocial outcomes. This study investigated associations among adolescent/young adults' initial experiences with NTPs, lifetime frequency of substance use, substance-related problems, and mental health symptoms.

methodAdolescents and young adults enrolled in a study on NTP and cannabis use were asked at what age they initiated the use of NTPs and were assigned to groups based on which product or substance(s) they reported using at the earliest age. Participants who reported use of NTPs (in isolation, without cannabis) first (

resultsGroups differed on lifetime frequency of NTP, simultaneous, and cannabis use, with NTP users reporting more substance use episodes and substance-related problems than the NTP-naïve group. The lifetime frequency of cannabis use did not differ across NTP use groups. NTP use was associated with increased anxiety and depression, with no significant differences between groups.

conclusionsAdolescents and young adults who use nicotine may be at increased risk for greater nicotine use and mental health consequences, but initiating NTP use simultaneously with cannabis may not increase the risk of negative outcomes above and beyond nicotine initiation. Prospective longitudinal research is needed to establish temporal associations between first-used NTP/cannabis products and relevant outcomes.

Indexed as

CannabisElectronic Nicotine Delivery SystemsHallucinogensMarijuana SmokingSubstance-Related DisordersTobacco Use DisorderAdolescentAdultHumansNicotineProspective StudiesTobacco ProductsYoung AdultHallucinogensNicotineadolescencecannabisco-useNicotineyoung adulthood

Identifiers

PMID38170177
PMCPMC10923017
OpenAlexW4390535910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.